Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.28
-0.01 (-0.78%)
At close: Sep 04, 2025, 3:59 PM
1.26
-1.44%
After-hours: Sep 04, 2025, 05:50 PM EDT
-0.78% (1D)
| Bid | 1.26 |
| Market Cap | 2.89M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.72M |
| EPS (ttm) | -5.61 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | -1.52 |
| Analyst | n/a |
| Ask | 1.3 |
| Volume | 36,929 |
| Avg. Volume (20D) | 321,911 |
| Open | 1.28 |
| Previous Close | 1.29 |
| Day's Range | 1.25 - 1.31 |
| 52-Week Range | 1.15 - 23.80 |
| Beta | 0.55 |
About GLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
4 months ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
11 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.
